Immunosuppressive drug therapy with plasmapheresis in chronic progressive multiple sclerosis: A controlled study
β Scribed by B. O. Khatri; G. J. Harrington; D. Schmoll; M. P. McQuillen
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 185 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
β¦ Synopsis
Although t h e e x a c t p a t h o g e n e s i s of m u l t i p l e s c l e r o s i s (MS) remains unknown, much r e c e n t d a t a s u g g e s t s t h a t M S may be an autoimmune d i s o r d e r .
The i n c r e a s e d p r o d u c t i o n of immunoglobulin (IgG) w i t h i n t h e blood b r a i n b a r r i e r (BBB) i n M S p a t i e n t s a f t e r c o r r e c t i n g f o r damage t o BBB [ 1 , 2 ] and a d e c r e a s e i n t h e numbers a n d / o r f u n c t i o n a l a c t i v i t y of
π SIMILAR VOLUMES
## Abstract ## Objective Rituximab, a monoclonal antibody selectively depleting CD20+ B cells, has demonstrated efficacy in reducing disease activity in relapsingβremitting multiple sclerosis (MS). We evaluated rituximab in adults with primary progressive MS (PPMS) through 96 weeks and safety thro
## Abstract ## Objectives To examine the acceptability of fluoxetine in elderly depressed patients with chronic obstructive pulmonary disease (COPD). ## Setting A university teaching hospital. ## Method Singleβblinded (open) study. One hundred and thirtyβseven outpatients (69 male) with sympto
## Abstract ## Objective Immunosuppressive agents have become the standard of therapy for proliferative lupus nephritis, but some patients may relapse after discontinuing treatment. We reviewed the cases of renal flares in a cohort of patients who participated in 2 randomized controlled clinical t